FDA approves Ventana Medical's breast cancer test

06/15/2011 | Wall Street Journal, The

Ventana Medical Systems, a Roche Holding subsidiary, has received FDA approval for its Inform Dual ISH genetic test, which is designed to identify patients who are likely to benefit from Herceptin, Genentech's breast cancer drug. The test works by looking for the presence of the HER2 gene in patients' tumor samples.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC